Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tectonic Therapeutic, Inc.

NASDAQ: TECX · Life Sciences · 4 alerts · CIK 1681087

Share price
$20.98Close, Nov 16
Market cap
$419M
Shares outstanding
19.95MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tectonic Therapeutic, Inc. filings on SEC EDGAR ↗

5:20 PM ET 8-K
Clinical Trial Data

Tectonic Therapeutic Clinical Trial Data

Tectonic Therapeutic announced favorable topline results from its Phase 1a clinical trial of TX2100, demonstrating that single ascending doses were generally safe and well-tolerated in healthy volunteers. The company also received FDA Fast Track designation and IND clearance to proceed with Phase 1b and Phase 2 trials in patients with Hereditary Hemorrhagic Telangiectasia (HHT).

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.